Advancements in technology are helping to overcome some of the challenges in drug screening:
Artificial Intelligence (AI): AI and machine learning algorithms can analyze large datasets to predict the efficacy and safety of compounds, speeding up the screening process. CRISPR: This gene-editing technology allows for precise modifications of genetic material, aiding in the identification and validation of new drug targets. Organoids and 3D Cell Cultures: These models better mimic the tumor environment compared to traditional 2D cultures, providing more accurate data on drug effects. Next-Generation Sequencing (NGS): NGS enables comprehensive profiling of cancer genomes, helping to identify mutations and pathways that can be targeted by new drugs.
